Image source: The Motley Fool.
Supernus Pharmaceuticals, inc (NASDAQ: SUPN)
Q2 2021 Earnings Call
Aug 4, 2021 , 4:30 p.m. ET
Operator
For further details see:
Supernus Pharmaceuticals, inc (SUPN) Q2 2021 Earnings Call TranscriptImage source: The Motley Fool.
Supernus Pharmaceuticals, inc (NASDAQ: SUPN)
Q2 2021 Earnings Call
Aug 4, 2021 , 4:30 p.m. ET
Operator
For further details see:
Supernus Pharmaceuticals, inc (SUPN) Q2 2021 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Supernus Pharmaceuticals Inc. Company Name:
SUPN Stock Symbol:
NASDAQ Market:
Supernus Pharmaceuticals Inc. Website:
ROCKVILLE, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report financial ...
ROCKVILLE, Md., May 30, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar, President and CEO of Supern...